Akoya Biosciences, Inc. (AKYA)
Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)
1.290
0.00 (0.00%)
Inactive · Last trade price on Jul 7, 2025
Akoya Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Akoya Biosciences stock had an average target of $2.51, with a low estimate of $1.08 and a high estimate of $5.00.
Price Target: $2.51 (+94.57%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for Akoya Biosciences stock from 7 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
87.60M
from 81.67M
Increased by 7.26%
Revenue Next Year
97.62M
from 87.60M
Increased by 11.44%
EPS This Year
-0.76
from -1.12
EPS Next Year
-0.60
from -0.76
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 97.7M | 110.3M | |||
| Avg | 87.6M | 97.6M | |||
| Low | 76.0M | 89.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.6% | 25.9% | |||
| Avg | 7.3% | 11.4% | |||
| Low | -7.0% | 1.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.46 | -0.36 | |||
| Avg | -0.76 | -0.60 | |||
| Low | -0.90 | -0.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |